Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.64B |
| 2 |
Microsoft
MSFT
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$1.17B |
| 4 |
Gilead Sciences
GILD
|
+$1.08B |
| 5 |
Eli Lilly
LLY
|
+$996M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.21B |
| 3 |
United Parcel Service
UPS
|
+$1.06B |
| 4 |
T-Mobile US
TMUS
|
+$908M |
| 5 |
McDonald's
MCD
|
+$883M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Financials | 15.98% |
| 3 | Healthcare | 15.38% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Edgewise Therapeutics
EWTX
$4.11B
| $1.48M | ﹤0.01% |
112,570
-733
| -0.6% | -$10.6K |
|
1552
Taysha Gene Therapies
TSHA
$1.66B
| $1.47M | ﹤0.01% |
635,968
+10,770
| +2% | +$23.4K |
|
1553
Skyworks Solutions
SWKS
$9.08B
| $1.46M | ﹤0.01% |
19,553
-2,700,497
| -99% | -$180M |
|
1554
Arcturus Therapeutics
ARCT
$168M
| $1.46M | ﹤0.01% |
111,907
+19,033
| +20% | +$225K |
|
1555
MeiraGTx Holdings
MGTX
$1.09B
| $1.45M | ﹤0.01% |
222,421
+15,441
| +7% | +$91.2K |
|
1556
ArriVent BioPharma
AVBP
$1.4B
| $1.44M | ﹤0.01% |
66,329
+4,981
| +8% | +$103K |
|
1557
Zebra Technologies
ZBRA
$13.9B
| $1.44M | ﹤0.01% |
4,665
+225
| +5% | +$61.1K |
|
|
AMTM
1558
Amentum Holdings
AMTM
$5.58B
| $1.43M | ﹤0.01% |
+60,778
| New | +$1.27M |
|
1559
Payoneer
PAYO
$2.41B
| $1.43M | ﹤0.01% |
348,966
-1,906,751
| -85% | -$12.9M |
|
1560
Nuvation Bio
NUVB
$2.18B
| $1.43M | ﹤0.01% |
733,542
+40,869
| +6% | +$85.1K |
|
1561
Rhythm Pharmaceuticals
RYTM
$6.88B
| $1.42M | ﹤0.01% |
22,425
-1,133
| -5% | -$69.4K |
|
1562
CubeSmart
CUBE
$9.55B
| $1.4M | ﹤0.01% |
33,032
+3,307
| +11% | +$137K |
|
1563
Cullinan Oncology
CGEM
$1.01B
| $1.4M | ﹤0.01% |
186,083
+25,026
| +16% | +$201K |
|
1564
PUT
ARK Innovation ETF
ARKK
$5.75B
| $1.4M | ﹤0.01% |
+26,160
| New | +$1.44M |
|
1565
Krystal Biotech
KRYS
$9.37B
| $1.4M | ﹤0.01% |
10,153
-446
| -4% | -$65.5K |
|
1566
Dianthus Therapeutics
DNTH
$5.82B
| $1.39M | ﹤0.01% |
74,351
+6,369
| +9% | +$119K |
|
1567
Vanda Pharmaceuticals
VNDA
$311M
| $1.38M | ﹤0.01% |
292,495
+26,607
| +10% | +$116K |
|
1568
Southern First Bancshares
SFST
$604M
| $1.37M | ﹤0.01% |
35,981
+1,872
| +5% | +$65.7K |
|
|
HIMX
1569
Himax Technologies
HIMX
$2.19B
| $1.35M | ﹤0.01% |
151,682
-305,143
| -67% | -$2.4M |
|
1570
Alamos Gold
AGI
$11.7B
| $1.35M | ﹤0.01% |
+50,945
| New | +$1.36M |
|
1571
SIGA Technologies
SIGA
$236M
| $1.35M | ﹤0.01% |
206,329
+24,001
| +13% | +$144K |
|
|
SWTX
1572
DELISTED
SpringWorks Therapeutics
SWTX
| $1.34M | ﹤0.01% |
28,460
-2,103
| -7% | -$93.6K |
|
1573
Rivian
RIVN
$22.5B
| $1.33M | ﹤0.01% |
96,789
+3,991
| +4% | +$54.1K |
|
1574
Cummins
CMI
$89.1B
| $1.33M | ﹤0.01% |
4,056
+527
| +15% | +$163K |
|
1575
Celcuity
CELC
$4.22B
| $1.33M | ﹤0.01% |
99,379
+14,554
| +17% | +$158K |
|
Similar funds
Wellington Management Group's Q2 2025 Portfolio in Review
As of Q2 2025, Wellington Management Group held 2,080 positions worth $551B, up 6% from $520B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group's Q2 2025 filing shows 139 new, 795 increased, 834 reduced and 147 closed positions. Its largest new stake was Amrize Ltd: 7,812,891 shares worth $388M. The largest sale was Procter & Gamble, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Wellington Management Group's largest Q2 2025 buy was Amrize Ltd: 7,812,891 shares worth $388M.
- Wellington Management Group added most to Alphabet (Google) Class A in Q2 2025, an estimated $1.64B increase.
- Wellington Management Group's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $1.38B.
- Wellington Management Group fully exited iShares Russell 1000 Growth ETF in Q2 2025, selling an estimated $464M.
- Wellington Management Group's ten largest holdings make up 25% of its $551B portfolio in Q2 2025.
- Wellington Management Group opened 139 new positions and closed 147 in Q2 2025.
- Wellington Management Group's portfolio value rose 6% quarter-over-quarter to $551B.
Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.